Cargando…

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency

X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations in the interleukin-2 receptor γ chain gene (IL2RG), and it is characterized by profound defects in T, B, and natural killer (NK) cell functions. Transplantation of hematopoietic stem/progenitor cells (HSPCs) genetically corre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poletti, Valentina, Charrier, Sabine, Corre, Guillaume, Gjata, Bernard, Vignaud, Alban, Zhang, Fang, Rothe, Michael, Schambach, Axel, Gaspar, H. Bobby, Thrasher, Adrian J., Mavilio, Fulvio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918176/ https://www.ncbi.nlm.nih.gov/pubmed/29707600 http://dx.doi.org/10.1016/j.omtm.2018.03.002

Ejemplares similares

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47(phox)-Deficient Chronic Granulomatous Disease
por: Schejtman, Andrea, et al.
Publicado: (2021)

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
por: Zhang, Fang, et al.
Publicado: (2007)

An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype
por: Weber, Leslie, et al.
Publicado: (2018)

Efficacy and biodistribution analysis of intracerebroventricular administration of an optimized scAAV9-SMN1 vector in a mouse model of spinal muscular atrophy
por: Armbruster, Nicole, et al.
Publicado: (2016)

Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
por: Cambon, Karine, et al.
Publicado: (2017)

Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy
por: Brendel, Christian, et al.
Publicado: (2020)

Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cells
por: Corre, Guillaume, et al.
Publicado: (2022)

Interactions between Retroviruses and the Host Cell Genome
por: Poletti, Valentina, et al.
Publicado: (2017)

Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration
por: Aranyi, Tamas, et al.
Publicado: (2016)

Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
por: Dahl, Maria, et al.
Publicado: (2020)

Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
por: Negre, Olivier, et al.
Publicado: (2015)

Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency
por: Topal, Joseph, et al.
Publicado: (2022)

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
por: Geis, Franziska K., et al.
Publicado: (2017)

Lentiviral vector transduction of spermatozoa as a tool for the study of early development
por: Chandrashekran, Anil, et al.
Publicado: (2014)

Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment
por: Navarro, Susana, et al.
Publicado: (2021)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application
por: Schott, Juliane W., et al.
Publicado: (2019)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
por: Geis, Franziska K., et al.
Publicado: (2017)

Construction of stable packaging cell lines for clinical lentiviral vector production
por: Sanber, Khaled S., et al.
Publicado: (2015)

Analyzing the Genotoxicity of Retroviral Vectors in Hematopoietic Cell Gene Therapy
por: Biasco, Luca, et al.
Publicado: (2017)

Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells
por: Leinonen, Hanna M., et al.
Publicado: (2019)

Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
por: Montiel-Equihua, Claudia A, et al.
Publicado: (2009)

Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations
por: Castiello, Maria Carmina, et al.
Publicado: (2023)

Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
por: Liu, Yang, et al.
Publicado: (2021)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)

Special Issue “Lentiviral Vectors”
por: Takeuchi, Yasuhiro
Publicado: (2022)

Lentiviral Vector Production Titer Is Not Limited in HEK293T by Induced Intracellular Innate Immunity
por: Ferreira, Carolina B., et al.
Publicado: (2019)

Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy
por: Counsell, John R., et al.
Publicado: (2017)

WAS Promoter-Driven Lentiviral Vectors Mimic Closely the Lopsided WASP Expression during Megakaryocytic Differentiation
por: Muñoz, Pilar, et al.
Publicado: (2020)

Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy
por: Odegard, Jared M., et al.
Publicado: (2015)

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
por: Gallinaro, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1mtnjj2os82seci4gquf2hqe1v